Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Johnson: Cardiac Abnormalities in Diabetic Patients With Neuropathy. (0.12 sec) 

Cardiac Abnormalities in Diabetic Patients With Neuropathy

- Free from Publisher
BF Johnson, RW Nesto, MA Pfeifer, WR Slater … - Diabetes Care, 2004 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—Diabetic subjects with neuropathy (n = 81) with
either a low diastolic peak filling rate or impaired augmentation of left
ventricular (LV) ejection fraction (LVEF) during maximal bicycle exercise ...
Cited by 34 - Related articles - BL Direct - All 8 versions

Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.


R Ramasamy, PJ Oates, S Schaefer - Diabetes, 1997 - Am Diabetes Assoc
Diabetes increases the incidence of cardiovascular disease as well as the
complications of myocardial infarction. Studies using animal models of diabetes
have demonstrated that the metabolic alterations occurring at the myocyte ...
Cited by 84 - Related articles - BL Direct - All 4 versions

[CITATION] Van Tol. A Elevation of plasma phospholipid transfer protein increases the risk of …


J Lie, R De Crom, T Van Gent, R Van Haperen … - J Lipid Res, 2004
Cited by 4 - Related articles

The marriage of glucose and blood vessels: it isn't all that sweet


WC Xiong, DM Stern - Cell Metabolism, 2005 - Elsevier
Diabetes begins as a disturbance in glucose metabolism, due to deficiency of or
resistance to the action of insulin, and expands to a disorder affecting
virtually every tissue. It is the complications of diabetes that ultimately ...
Cited by 4 - Related articles - All 6 versions

Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and …


H OKAMOTO, M NOMURA, Y NAKAYA, K … - Internal Medicine, 2003 - Journal@rchive
Objective Diabetic patients with severe autonomic nervous disorder show delayed
gastric emptying accom- panied by diabetic gastroparesis, which decreases the
electric activity of the stomach associated with gastric motility. It is ...
Cited by 24 - Related articles - BL Direct - All 4 versions

Aldose reductase activation is a key component of myocardial response to ischemia

- fasebj.org [PDF] 
YC Hwang, S Sato, JY Tsai, SD Yan, S Bakr, … - The FASEB Journal, 2001 - FASEB
Page 1. The FASEB Journal express article 10.1096/fj.01-0368fje. Published online
December 28, 2001. Aldose reductase activation is a key component of ...
Cited by 43 - Related articles - BL Direct - All 4 versions

Aldose reductase: a novel target for cardioprotective interventions


R Ramasamy - Current Drug Targets, 2003 - ingentaconnect.com
Abstract: Recanalization therapy remains the most effective way for treatment of
evolving myocardial infarction and thereby salvaging jeopardized tissue.
However, the efficacy of reperfusion in limiting infarction and improving ...
Cited by 11 - Related articles - BL Direct - All 2 versions

Left ventricular systolic and diastolic function in normotensive type 1 diabetic patients with …

- newlinemedical.com [PDF]  - Free from Publisher
TP Didangelos, GA Arsos, DT Karamitsos, VG … - Diabetes Care, 2003 - Am Diabetes Assoc
RESULTS—There were 24 patients who had definite DAN, established by the
presence of two or more abnormal ANF tests, and 33 subjects were without DAN.
DAN patients had impaired LV filling pattern, obvious by a reduced peak ...
Cited by 25 - Related articles - BL Direct - All 6 versions

Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient …

- diabetesjournals.org [PDF] 
P Keren, J George, A Shaish, H Levkovitz, Z … - Diabetes, 2000 - Am Diabetes Assoc
Diabetes and atherosclerosis have been proposed to be influenced by immune and
autoimmune mechanisms. A common incriminated antigen in both disorders is the
heat shock protein (HSP)-60/65. In the current study, we established a ...
Cited by 35 - Related articles - BL Direct - All 5 versions

Hyperlipidemia and atherosclerosis in experimental insulinopenic diabetic monkeys.


Y Harano, H Kojima, K Kosugi, M Suzuki, M … - Diabetes research and clinical practice, 1992 - ncbi.nlm.nih.gov
Chronic insulinopenic diabetes was induced by iv streptozotocin in the non-human
primate Macaca fuscata. Five diabetic monkeys were kept for 8-19 months and nine
for 24-48 months without any insulin treatment. Hyperglycemia (241 +/- 22 ...
Cited by 14 - Related articles - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google